Lv1
30 积分 2026-02-02 加入
Progress with FAK inhibitors in the patent literature (2020-present)
10小时前
待确认
Targeting B Cells and Plasma Cells in Glomerular Disease
2个月前
已完结
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity
5个月前
已完结
A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of Lymphoma
5个月前
已完结
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2 -deficient Mesothelioma
6个月前
已完结
New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors
7个月前
已完结
Translational Research on the Oral Delivery of the Cytotoxic PROTAC Molecule via Tumor-Targeting Prodrug Strategy for Triple-Negative Breast Cancer Treatment
7个月前
已完结
Property based optimization of heterobifunctional degraders of KAT2A and KAT2B for the treatment of cancer
7个月前
已完结
Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia
7个月前
已完结
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
7个月前
已完结
皖公网安备34019202002308
